| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 06/29/1999 | US5917670 In a hard disk drive |
| 06/29/1999 | US5916808 Hybridizing to pre-messenger rna at splice element of native intron, thus creating duplex and permitting splicing; oligonucleotide does not activate rnaase h and blocks mutant splice elements; treatment of beta-thalassemia |
| 06/29/1999 | US5916807 Inhibiting gene expression of enzyme by contacting cells with synthetic antisense agent; used as anticarcinogenic/antiproliferative/antiinflammatory agents |
| 06/29/1999 | US5916803 Target cell-specific non-viral vectors for inserting genes into cells, pharmaceutical compositions comprising such vectors and their use |
| 06/29/1999 | US5916792 Jak3 plays a role in the growth factor modulated differentiation/proliferation of the stem/progenitor cells. |
| 06/29/1999 | US5916769 Polynucleotides encoding extra cellular/epidermal growth factor HCABA58X polypepides |
| 06/29/1999 | US5916766 Human marco scavenger receptor |
| 06/29/1999 | US5916763 Promoter for VEGF receptor |
| 06/29/1999 | US5916752 Telomerase screening methods |
| 06/29/1999 | US5916556 Human MRNA editing enzyme |
| 06/29/1999 | CA2125974C Senescent cell derived inhibitors of dna synthesis |
| 06/24/1999 | WO1999031262A2 Needle-free injection of formulated nucleic acid molecules |
| 06/24/1999 | WO1999031261A1 SELECTIVE KILLING AND DIAGNOSIS OF p53+ NEOPLASTIC CELLS |
| 06/24/1999 | WO1999031260A2 Regulatory sequences involved in pancreas-specific gene expression |
| 06/24/1999 | WO1999031251A1 Method and means for producing high titer, safe, recombinant lentivirus vectors |
| 06/24/1999 | WO1999031240A2 14-3-3σ ARRESTS THE CELL CYCLE |
| 06/24/1999 | WO1999031239A1 HUMAN Nap1 PROTEIN |
| 06/24/1999 | WO1999031230A2 Oligophrenin-1, its expression product, and the diagnostic and therapeutic applications thereof |
| 06/24/1999 | WO1999031227A2 NOVEL PEPTIDE, apoEp1.B, COMPOSITIONS AND USES THEREOF |
| 06/24/1999 | WO1999031136A2 Methods for maintaining or restoring tissue-appropriate phenotype of soft tissue cells |
| 06/24/1999 | WO1999031134A1 Glucose regulated gene |
| 06/24/1999 | WO1999031119A1 Platelet derived growth factor (pdgf) nucleic acid ligand complexes |
| 06/24/1999 | WO1999031118A1 Inhibition of tumor cells proliferation using ribozymes |
| 06/24/1999 | WO1999031117A1 110 human secreted proteins |
| 06/24/1999 | WO1999030743A1 Methods for evaluating a compound for its effect on skin |
| 06/24/1999 | WO1999030742A1 Therapeutic use of lentiviral vectors |
| 06/24/1999 | WO1999030741A2 Agent for gene therapy of tumor, neurodegenerative, cardiovascular and autoimmune diseases |
| 06/24/1999 | WO1999030736A2 Methods to treat undesirable immune responses |
| 06/24/1999 | WO1999030735A1 UGC (UPSTREAM GENE OF cdsA) |
| 06/24/1999 | WO1999030734A1 Venezuelan equine encephalitis virus vectors expressing tumor-associated antigens to induce cancer immunity |
| 06/24/1999 | WO1999030733A1 Method to enhance an immune response of nucleic acid vaccination |
| 06/24/1999 | WO1999030730A1 Methods and compositions for improving the success of cell transplantation in a host |
| 06/24/1999 | WO1999030648A1 Pluripotential bone marrow cell line and methods of using the same |
| 06/24/1999 | WO1999019359A9 Cellular receptor for hiv-1 vpr essential for g2/m phase transition of the cell cycle |
| 06/24/1999 | WO1999019352A3 Methods and compositions to alter the cell surface expression of phosphatidylserine and other clot-promoting plasma membrane phospholipids |
| 06/24/1999 | WO1999018197A3 Nucleic acid molecule encoding a (poly)peptide co-segregating in mutated form with autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (apeced) |
| 06/24/1999 | WO1999016888A3 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor |
| 06/24/1999 | WO1999016787A9 Cell death agonists |
| 06/24/1999 | WO1998051792A8 Fac molecules and uses thereof |
| 06/24/1999 | WO1998018951A8 Receptor-mediated gene transfer system for targeting tumor gene therapy |
| 06/24/1999 | DE19754938A1 TGC-Verfahren zur Induktion einer zielgerichteten, somatischen Transgenität TGC method for inducing a targeted somatic transgenic |
| 06/24/1999 | CA2315537A1 Methods to treat undesirable immune responses |
| 06/24/1999 | CA2315295A1 110 human secreted proteins |
| 06/24/1999 | CA2315268A1 Oligophrenin-1, its expression product, and the diagnostic and therapeutic applications thereof |
| 06/24/1999 | CA2315256A1 Needle-free injection of formulated nucleic acid molecules |
| 06/24/1999 | CA2314909A1 Human nap1 protein |
| 06/24/1999 | CA2314821A1 Methods for maintaining or restoring tissue-appropriate phenotype of soft tissue cells |
| 06/24/1999 | CA2314683A1 Therapeutic use of lentiviral vectors |
| 06/24/1999 | CA2314609A1 Method and means for producing high titer, safe, recombinant lentivirus vectors |
| 06/24/1999 | CA2314141A1 Glucose regulated gene |
| 06/24/1999 | CA2313005A1 Method to enhance an immune response of nucleic acid vaccination |
| 06/24/1999 | CA2309765A1 Venezuelan equine encephalitis virus vectors expressing tumor-associated antigens to induce cancer immunity |
| 06/24/1999 | CA2309555A1 Selective killing and diagnosis of p53+ neoplastic cells |
| 06/23/1999 | EP0924297A1 Sialoadhesin family member-2 (saf-2) |
| 06/23/1999 | EP0923740A2 Methods and compositions for the detection of cervical cancer |
| 06/23/1999 | EP0923646A1 Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis |
| 06/23/1999 | EP0923604A1 Cysteine-containing or methioine-containing peptides with immunomodulatory effects |
| 06/23/1999 | EP0923600A2 Novel cationic amphiphilic lipids for liposomal gene transfer |
| 06/23/1999 | EP0923284A1 Cellular immunogens useful as cancer vaccines |
| 06/23/1999 | CN1220701A Lipid kinase |
| 06/23/1999 | CN1220608A Mammalian tolloid-like gene and protein |
| 06/22/1999 | US5914395 Desmin enhancer sequences, vectors comprising these sequences and their uses in compositions for the expression of nucleotide sequences in transfected cells |
| 06/22/1999 | US5914265 Keratin K1 expression vectors and methods of use |
| 06/22/1999 | US5914234 Methods of detecting growth differentiation factor-11 |
| 06/22/1999 | US5914231 Carrier of cationic, water soluble or water dispersable polymer; for gene therapy |
| 06/22/1999 | US5914126 Methods to deliver macromolecules to hair follicles |
| 06/22/1999 | US5914106 Interleukin-6 receptor agonists |
| 06/20/1999 | CA2255143A1 Binding partners for inhibitors of cyclin-dependent kinases and their use for searching for inhibitors and for the diagnosis or therapy of a disease |
| 06/20/1999 | CA2255141A1 Nucleic acid constructs for gene therapy whose activity is affected by inhibitors of cyclin-dependent kinases |
| 06/17/1999 | WO1999030157A2 Neuropilins in methods for diagnosis and prognosis of cancer |
| 06/17/1999 | WO1999029884A2 Tgc method for inducting targeted somatic transgenesis |
| 06/17/1999 | WO1999029883A2 Targeting antigen-specific t cells for specific immunotherapy of autoimmune disease |
| 06/17/1999 | WO1999029878A2 Methods of producing anti-angiogenic proteins: endostatin, angiostatin or restin, using a pichia yeast expression system |
| 06/17/1999 | WO1999029871A2 Circovirus sequences related to piglet weight loss disease (pwd) |
| 06/17/1999 | WO1999029865A2 A protein belonging to the tnf superfamily, nucleic acids encoding same, and methods of use thereof |
| 06/17/1999 | WO1999029861A1 Peptide antagonists of vascular endothelial growth factor |
| 06/17/1999 | WO1999029860A1 Cadherin-like polypeptides, methods and compositions related thereto |
| 06/17/1999 | WO1999029858A1 Soluble inhibitors of vascular endothelial growth factor and use thereof |
| 06/17/1999 | WO1999029856A1 Restin and methods of use thereof |
| 06/17/1999 | WO1999029855A1 Mutants of endostatin, 'em 1' having anti-angiogenic activity and methods of use thereof |
| 06/17/1999 | WO1999029853A1 Cadherin-like polypeptides, methods and compositions related thereto |
| 06/17/1999 | WO1999029852A1 High-affinity tryptophan transporter |
| 06/17/1999 | WO1999029848A1 Novel vectors and genes exhibiting increased expression |
| 06/17/1999 | WO1999029844A2 Novel retroelements zam and idemfix, and their integrase |
| 06/17/1999 | WO1999029843A1 Hepatitis c virus ns5b truncated protein and methods thereof to identify antiviral compounds |
| 06/17/1999 | WO1999029842A1 Nucleic acid mediated rna tagging and rna revision |
| 06/17/1999 | WO1999029839A1 Grafted copolymers as gene carriers |
| 06/17/1999 | WO1999029731A1 Use of substances with immunomodulating activity for the treatment of amyotrophic lateral sclerosis |
| 06/17/1999 | WO1999029729A2 Antagonists of neuropilin receptor function and use thereof |
| 06/17/1999 | WO1999029728A1 Method and composition to enhance the efficacy of a vaccine using chemokines |
| 06/17/1999 | WO1999029712A1 Peptide-based gemini compounds |
| 06/17/1999 | WO1999029350A1 Compositions and methods for treatment of hepatitis c virus-associated diseases |
| 06/17/1999 | WO1999029349A1 Transfection particles |
| 06/17/1999 | WO1999029341A2 Methods for enhancement of protective immume responses employing leishmania polypeptides |
| 06/17/1999 | WO1999029334A1 CtIP, A NOVEL PROTEIN THAT INTERACTS WITH CtBP AND USES THEREFOR |
| 06/17/1999 | WO1999029310A2 Regulation of t cell-mediated immunity by tryptophan and its analogs |
| 06/17/1999 | WO1999029304A1 Method for high supercoiled dna content microspheres |
| 06/17/1999 | WO1999029303A1 Biodegradable mixed polymeric micelles for gene delivery |
| 06/17/1999 | WO1999013064A3 Viral infection of cells using viral vectors |
| 06/17/1999 | WO1999009162A3 Delayed progression to aids by a missense allele of the ccr2 gene |